Position in ATYR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,512
+$25,306 QoQ
Shares Held
66,185
+263.4% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 90 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. ATYR ranks #125 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
676,247 | $335,912,169 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
382,028 | $238,209,735 | |
| 3 | INCY |
Incyte Corp
|
1,307,743 | $148,245,744 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,224,925 | $68,681,542 | |
| 5 | MRNA |
Moderna, Inc.
|
636,199 | $44,553,014 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
115,279 | $34,702,435 | |
| 7 | INSM |
INSMED Inc
|
279,961 | $29,849,438 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
307,543 | $17,597,610 |
All Filings in ATYR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,512 | 66,185 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $14,206 | 18,214 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $12,634 | 16,136 | Shares | Defined | 2026-03-06 | |
| 2025-09-30 | $11,636 | 16,139 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $124,640 | 24,584 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||